Characterization of inhalation aerosols: A critical evaluation of cascade impactor analysis and laser diffraction technique

International Journal of Pharmaceutics

Volumn 249, Issue 1-2, 2002, Pages 219-231

  De Boer, A H ^a   Gjaltema, D ^a   Hagedoorn, P ^a   Frijlink, H W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Aerodynamic diameter; Aerosol cloud; Cascade impactor; Inhalation; Laser diffraction; Particle size analysis

Indexed keywords

AEROSOL; ANALYSIS; ARTICLE; AUTOMATION; DRY POWDER; EVALUATION; FLOW RATE; IN VITRO STUDY; INFORMATION PROCESSING; LASER DIFFRACTION; PARTICLE SIZE; PRIORITY JOURNAL; TECHNIQUE; CHEMISTRY; DRUG SCREENING; INHALATIONAL DRUG ADMINISTRATION; INSTRUMENTATION; LASER; METHODOLOGY;

ADMINISTRATION, INHALATION; AEROSOLS; DRUG EVALUATION, PRECLINICAL; LASERS;

EID: 0037027831     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00526-4     Document Type: Article

References (34)

1. Annapragada A., Adjei A. An analysis of the Fraunhofer diffraction method for particle size distribution analysis and its application to aerosolized sprays. Int. J. Pharm. 127:1996;219-227.
2. Asking L., Olsson B. Calibration at different flow rates of a multistage liguid impinger. Aerosol Sci. Technol. 27:1997;39-49.
3. Boeck, T., 1983. Entwicklung eines photometrischen on-line Oberflächenmessverfahrens für trockene, disperse Feststoffe. Thesis, TU Clausthal.
4. de Boer A.H., Bolhuis G.K., Gjaltema D., Hagedoorn P. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 3: the effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler. Int. J. Pharm. 153:1997;67-77.
5. de Boer A.H., Gjaltema D., Witt W., Frijlink H.W. The use of laser diffraction technique for the characterization of the aerosol cloud from inhalation devices. Dalby R.N., Byron P.R., Farr S.J., Peart J., Resp. Drug Delivery VII. 2000;585-588 Serentec Press, Raleigh.
6. Bridges P.A., Taylor K.M.G. Nebulizers for the generation of liposomal aerosols. Int. J. Pharm. 173:1998;117-125.
7. Brindley A., Sumby B.S., Smith I.J. The characterization of inhalation devices by an inhalation simulator: the Electronic Lung™ J. Aerosol Med. 7:1994;197-200.
8. British Pharmacopoeia, 1988. Appendix XVII C, A, pp. 204-207.
9. Byron P.R. Some future perspectives for unit dose inhalation aerosols. Drug Dev. Ind. Pharm. 12:1986;993-1015.
10. Clark A.R. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int. J. Pharm. 115:1995;69-78.
11. Davies P.J., Hanlon G.W., Molyneux A.J. An investigation into the deposition of inhalation aerosol particles as a function of air flow rate in a modified 'Kirk Lung'. J. Pharm. Pharmacol. 28:1976;908-911.
12. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M.-L., Mintzes J., Deaver D., Lotan N., Langer R. Large porous particles for pulmonary drug delivery. Science. 276:1997;1868-1871.
13. Graseby-Anderson, Inc., 1985 ACFM non-viable ambient particle sizing sampler operating manual. Graseby-Andersen, Inc., Smyrna, GA.
14. Hickey A.J. An investigation of size deposition upon individual stages of a cascade impactor. Drug Dev. Ind. Pharm. 16:1990;1911-1929.
15. Hindle M., Byron P.R., Miller N.C. Cascade impaction methods for dry powder inhalers using the high flowrate Marple-Miller Impactor. Int. J. Pharm. 134:1996;137-146.
16. Hinds W.C. Aerosol Technology. Properties, Behavior, and Measurement of Airborne Particles. 1982;Wiley, New York.
17. Ho K.K.L., Kellaway I.W., Tredree R. Particle size analysis of nebulized aerosols using Fraunhofer laser diffraction and inertial impaction methods. J. Pharm. Pharmacol. 38:1986;S26P.
18. Hurley P.K., Smye S.W., Cunliffe H. Assessment of antibiotic aerosol generation using commercial jet nebulizers. J. Aerosol Med. 7:1994;217-228.
19. John W. A simple derivation of the cutpoint of an impactor. J. Aerosol Sci. 30:1999;1317-1320.
20. Marple V.A., Roberts D., Romay F.J. Design of the next generation pharmaceutical impactor. Drug Delivery to the Lungs-XI. 2000;UK Aerosol Society, London.
21. Martonen T.B., Katz I.M. Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters. Pharm. Res. 10:1993;871-878.
22. McCallion O.N.M., Taylor K.M.G., Thomas M., Taylor A.J. Nebulization of fluids of different physiochemical properties with air-jet and ultrasonic nebulizers. Pharm. Res. 12:1995;1682-1688.
23. McCallion O.N.M., Taylor K.M.G., Thomas M., Taylor A.J. The influence of surface tension on aerosols produced by medical nebulizers. Int. J. Pharm. 129:1996;123-136.
24. Moore, A., 2001. The relevance of aerosol deposition models to dry powder inhalers. Presentation at the Management Forum Conference: Advances in dry powder inhalers. London, UK.
25. Morén F. Dosage forms and formulations for drug administration to the respiratory tract. Drug Dev. Ind. Pharm. 13:1987;695-728.
26. Müller R.H., Schuhmann R. Teilchengrößenmessung in der Laborpraxis. 1996;65-70 Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany.
27. Niven R.W., Lott F.D., Ip A.Y., Somaratne K.D., Kearney M. Development and use of an in vitro system to evaluate inhaler devices. Int. J. Pharm. 101:1994;81-87.
28. Olsson B., Aiache J.M., Bull H., Ganderton D., Haywood P., Meakin B.J., Schorn P.J., Wright P. The use of inertial impactors to measure the fine particle dose generated by inhalers. Pharmeuropa. 8:1996;291-298.
29. Olsson B., Borgström L., Asking L., Bondesson E. Effect of inlet thoat on the correlation between measured fine particle dose and lung deposition. Resp. Drug Delivery. V:1996;273-281.
30. Ranucci, J., 1992. Dynamic plume-particle size analysis using laser diffraction. Pharm. Technol. October, 108-114.
31. Ranz W.E., Wong J.B. Impaction of dust and smoke particles. Ind. Eng. Chem. 44:1952;1371-1381.
32. Ranz W.E., Wong J.B. Jet impactors for determining the particle-size distributions of aerosols. AMA Arch. Ind. Hyg. Occup. Med. 5:1952;464-477.
33. Staniforth, J., 1995. Improvements in and relating to carrier particles for use in dry powder inhalers. WO95/11666.
34. Vidgrén M. Factors influencing lung deposition of inhaled aerosols. Eur. Repir. Rev. 4:1994;68-70.